Loading ASND charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading ASND comparable companies…
| ASNDAscendis Pharma A/S(opens in a new tab) | $15.38B | $0.82B | +110.1% | 86.9% | −17.7% | — | — |
|---|---|---|---|---|---|---|---|
| CORTCorcept Therapeutics Inc.(opens in a new tab) | $9.60B | $0.83B | +16.0% | 98.3% | 0.8% | 11.56× | 193.1× |
| COLLCollegium Pharmaceutical, Inc.(opens in a new tab) | $0.77B | $0.81B | +14.3% | 60.0% | 19.5% | 0.96× | 19.2× |
| TGTXTG Therapeutics, Inc.(opens in a new tab) | $9.63B | $0.80B | +76.1% | 82.4% | 17.1% | 12.04× | 22.3× |
| SUPNSupernus Pharmaceuticals, Inc.(opens in a new tab) | $2.49B | $0.87B | +26.9% | 87.6% | −5.7% | 2.88× | — |
| Medianpeers, excl. ASND | $6.05B | $0.82B | +21.5% | 85.0% | 8.9% | 7.22× | 22.3× |